DALLAS & YORK, U.K.--(BUSINESS WIRE)--Authentix, Inc.®, announced that it is working with longtime partner, AstraZeneca, to safeguard patients and to protect the integrity of the legitimate supply chain with the rollout of unit-level serialised tamper evident security seals (TESS) combined with unique carton numbers (UCN). When the Serialised Authentication Program launches next quarter, AstraZeneca will become one of the first pharmaceutical companies to implement a comprehensive system to serialise and authenticate its pharmaceutical products down to the unit-level.
